BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20684326)

  • 1. [Modified serum-guided immunoblotting for differential proteomic study of prostate cancer].
    Zhang XB; Tang ZY; Zu XB; Qi L; Ruan JD
    Zhonghua Nan Ke Xue; 2010 May; 16(5):438-44. PubMed ID: 20684326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of secreted proteins of non-small cell lung cancer.
    Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H
    Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer.
    Huang LJ; Chen SX; Huang Y; Luo WJ; Jiang HH; Hu QH; Zhang PF; Yi H
    Lung Cancer; 2006 Oct; 54(1):87-94. PubMed ID: 16876904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening of differentially expressed proteins from human esophageal cancer and esophageal tissues by two-dimensional difference gel electrophoresis and mass spectrometry].
    Huang ZY; Xiong G; Zhang J; Wang WJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1406-9. PubMed ID: 17884789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
    Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
    J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of prostate cancer by proteomics using tissue specimens.
    Liu AY; Zhang H; Sorensen CM; Diamond DL
    J Urol; 2005 Jan; 173(1):73-8. PubMed ID: 15592032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential phosphoprotein levels and pathway analysis identify the transition mechanism of LNCaP cells into androgen-independent cells.
    Wang HQ; Yang B; Xu CL; Wang LH; Zhang YX; Xu B; Ji JT; Sun YH
    Prostate; 2010 Apr; 70(5):508-17. PubMed ID: 19937597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A proteomic study of the serum proteins in BPH and HGPIN patients].
    Gu XJ; Zhu QY; Yuan L; Su J; Huang WZ; Zhang Y; Sun ZY
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):62-6. PubMed ID: 18297816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].
    Gan L; Yin ZF; Li M
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):419-21. PubMed ID: 18581899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF].
    Zhao Q; Duan W; Wu YM; Qian XH; Deng XH
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):754-8. PubMed ID: 19173805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential proteome analysis of conditioned medium of BPH-1 and LNCaP cells.
    Chen WZ; Pang B; Yang B; Zhou JG; Sun YH
    Chin Med J (Engl); 2011 Nov; 124(22):3806-9. PubMed ID: 22340245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuclear matrix proteins differentially expressed in human prostate cancer cell lines and benign prostatic hyperplasia epithelial cell line].
    Sun TC; Xin L; Song LM; Zhou Y; Ning LF; Han LY; Guo Y; Yu HM; Wang HP
    Zhonghua Nan Ke Xue; 2012 Jul; 18(7):583-9. PubMed ID: 22994041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum proteomic study of prostate cancer with bone metastasis].
    Zhang XM; Shen Y; Xianyu ZQ
    Zhonghua Nan Ke Xue; 2010 Aug; 16(8):721-5. PubMed ID: 21090348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.